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Brief summary: TVT has high long-term safety and efficacy. Mixed urinary incontinence is 
a risk factor for long-term recurrence.
Abbreviations  
TVT – tension-free vaginal tape
SUI – stress urinary incontinence
MUI – mixed urinary incontinence
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UI – urinary incontinence
UR – urinary retention
Key message: 
TVT is a surgical method with high safety and efficacy with low risk of serious long-term 
tape complications. However, mixed urinary incontinence predicts lower long-term cure.
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Introduction: The retropubic tension-free vaginal tape has been the preferred method for 
primary surgical treatment of stress urinary incontinence and stress dominated mixed urinary 
incontinence in women for more than 20 years. This study presents long-term safety and 
efficacy data and assesses risk factors for long-term recurrence.
Material and methods: In a case-series design we assessed a historical cohort of primary 
surgeries performed with the tension-free vaginal tape procedure in 596 women from 1998 to 
2012 with follow-up through 2015. Information from the medical records was transferred to a 
case report form comprising data on early and late complications and recurrence of urinary 
incontinence defined as bothersome stress urinary incontinence symptoms. All analyzes were 
performed with SPSS using Pearson Chi-Square, survival and Cox regression analyzes.
Results: After a 10-year follow-up mixed urinary incontinent women (HR 2.1, 95% CI; 1.4-
3.0) had a significant increased risk of recu rence of stress urinary incontinence symptoms 
compared to women with pure stress urinary incontinence as indication for surgery. Overall 
cumulative cure rates after one, five and 10 years were 92% (95% CI; 90-94%), 79% (95% 
CI; 75-83%) and 69% (95% CI; 63-75%), respectively.  Recurrent surgery (0.3%) and serious 
tape complications needing major surgical treatment (0.3%) were rare. Six patients (1.0%) 
had the tape cut due to urinary retention, and nine patients (1.5%) reported urinary retention 
more than three months after surgery.
Conclusion: The tension-free vaginal tape procedure has a high long-term durability. Mixed 
urinary incontinence as indication for surgery predicted long-term recurrence. Long-term 
complications were rare. 
Word count: 251
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Within a few years after the introduction of the retropubic tension-free vaginal tape (TVT) in 
1996, several studies demonstrated excellent short-term clinical outcomes, making this 
minimally invasive method the gold standard in the surgical treatment of women with stress 
(SUI) and stress-dominated mixed (MUI) urinary incontinence. 1-2  From 2005 and onwards, 
the number of women undergoing midurethral sling surgery increased rapidly. 3  Probable 
explanations are an increased awareness of urinary incontinence (UI), a lower symptom 
threshold for surgery, as the surgical method is considered less invasive, and a possible 
increase in prevalence of UI. 4
To date, several studies assessing clinical outcomes and risk factors for failure have 
demonstrated excellent long-term clinical outcomes after midurethral sling surgery. However, 
patient selection varies according to indication for surgery, the inclusion of women with 
repeat UI surgery and women with previous and/or concomitant prolapse surgery. 5-10  Most 
long-term follow-up studies do not have sample sizes large enough for risk factor analysis. 5-7 
The highest long-term subjective cure rates of 77-90% apply only to primary surgery on pure 
SUI women, 5, 11 whereas subjective cure rates of 75-80% are reported for heterogeneous 
populations of women with both SUI and MUI. 6, 12  Long-term studies including women with 
previous/concomitant pelvic surgery have reported lower subjective cure rates (65-76%). 7-8 
Subjective cure rates as low as 37-55% have been reported for MUI women, only. 13-14 
Therefore, study population characteristics are crucial when comparing studies and may 
explain why clinical outcomes and risk factor patterns for recurrence vary.
MUI as an independent risk factor for recurrence is well established, 13-15 but across studies 
age, body mass index and diabetes are inconsistently reported. 6, 9, 13, 15  The possible impact of 
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perioperative complications on long-term efficacy has only been evaluated in a few studies. 9, 
15 
The aims of this study were to investigate clinical long-term outcomes, and to assess 
demographic, clinical and perioperative risk factors for recurrence within 10 years after 
primary retropubic TVT surgery.
Material and methods
The Department of Gynecology at Nordland Hospital, Bodø, Norway, introduced the 
retropubic TVT procedure in 1998. Within a year, TVT had replaced the Burch 
colposuspension as the preferred method. We identified all patients having undergone a 
possible UI-related surgical procedure during 1994-2012 either as primary or recurrence 
surgery, in total 895 women (Figure 1). After exclusions of women having had Burch 
procedures on solely prolapse indication, past pelvic surgery, concomitant prolapse surgery, 
primary incontinence surgery other than TVT, and women with no follow-up, the final study 
population comprised 596 women having had TVT as primary surgery for SUI or MUI. The 
TVT surgery was performed as originally described by Ulmsten.1  All patients received 
prophylactic antibiotics, and we used the surgical kits from Johnson & Johnson.
We screened the electronic medical records retrospectively and transferred the information to 
a case report form especially designed for the study. The following preoperative data were 
included: type of UI (SUI/MUI), age at time of surgery (≤49, 50-59, ≥60 years), parity (0-1, 2, 
3+), body mass index, past hysterectomy (total and subtotal) and relevant comorbidities 
(cardiovascular disease/diabetes (0/1), pulmonary disease (0/1) and neurological disease 
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(0/1)). From the preoperative examination prior to primary surgery, we collected the 
following information: previous conservative treatment for UI (pelvic floor muscle training 
and electrical stimulation), uroflowmetry assessments (including the shape of the curve and 
the estimate of maximum flow rate (< or ≥ 15 ml/s)). In addition, the results from two 
standardized stress-tests (coughing during gynecological examination with 300 ml saline in 
the bladder and/or pad weight before and after three forceful coughs and 20 jumping jacks 
(sideways splits)) and cystometry as well as measurement of residual urine (ml) were 
included. 16-17 
The classification of the type of incontinence was based on a combination of symptoms 
documented in the medical record, outcome of stress tests and/or urodynamic examinations 
and a standardized validated short-form UI disease-specific questionnaire used from 2002 and 
onwards. 18 We defined SUI as bothersome symptoms of SUI as described in the medical 
record and/or in the standardized questionnaire in combination with a positive stress test. MUI 
was defined as a combination of a dominant SUI component and urgency urinary 
incontinence defined as description of bothersome symptoms of involuntary leakage of urine 
after sudden urgency to void in the medical record and/or in the standardized questionnaire. A 
positive cystometry was not mandatory for a diagnosis.
Primary outcome was recurrence of UI defined as the presence of any bothersome symptoms 
of SUI reported by the patient and/or by a stress urinary incontinence index score > 0 
indicative of bothersome symptoms of SUI on the validated questionnaire, and/or a positive 
standardized stress test at follow-up. Neither de novo urgency urinary incontinence in women 
with pure SUI before surgery nor recurrence of urgency urinary incontinence in women with 
preoperative MUI was defined as recurrence.
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Secondary outcomes were urinary retention (UR), other perioperative complications and late 
tape complications. 
UR was defined as the need for catheterization more than one week after primary surgery 
and/or in need of traction and/or surgical correction necessitating cutting of the tape. Traction 
was performed non-invasively by stretching the urethra with a Hegar dilator in gel anesthesia. 
Other perioperative complications comprised bladder injury defined as perforation by the 
trocar or by the tape, hematoma defined as clinical significant and/or ultrasonographically 
identified hematomas of any size and other complications. We chose not to include urinary 
infections as complication as the prevalence will be underestimated when these infections 
most often are treated post discharge by general practitioners.
We defined late tape complications as symptomatic or asymptomatic erosions, fistulas, and 
symptoms of dyspareunia and/or chronic pain/discomfort diagnosed three months or later 
after primary surgery. Recurrent urinary infections without any other complaints were not 
considered to be a late complication, and de novo urgency urinary incontinence in SUI 
women was not included in the study.
All patients were offered a follow up after 6-12 months with an interview and a clinical 
examination, followed by urodynamics, if bothersome symptoms. In the interview the women 
were asked about their satisfaction with the treatment, and from 2002 and onwards the 
department used a standardized questionnaire including the categories “very satisfied”, 
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“satisfied”, “neither satisfied nor dissatisfied”, “dissatisfied” and “very dissatisfied”. For 
patients residing far from our hospital, we performed an interview by post or phone.
Later follow-up data was based on consultations at our outpatient clinic after referral from 
general practitioners or private gynecologists. For patients not residing in our hospital’s local 
catchment area (n = 166), we retrieved follow-up data from the medical records at relevant 
local hospitals from in- and/or outpatient visits. As the department introduced a standardized 
3-year follow-up using the validated short-form UI disease-specific questionnaire from 2009 
and onwards, we assessed changes in outcomes in three different time periods (1998-2003, 
2004-2008 and 2009-2012).
Statistical analysis
In this case-series, the data were analyzed using SPSS version 25.  Pearson Chi-Square test 
was used when comparing SUI and MUI, survival analysis (life tables) when estimating 
cumulative cure rates of TVT and Cox regression analysis in the risk factor analysis of 
recurrence. In the survival analysis and the Cox regression analysis of recurrence, UI was 
recorded at the date of the first visit for bothersome symptoms of SUI following primary 
surgery, or censored at the date of last visit being continent as documented in the medical 
record, or at the date of repeat surgery due to complications or prolapse, when repeat surgery 
occurred prior to debut of SUI symptoms. All analyzes stopped for any outcome at 10 years of 
follow-up due to few observations thereafter. Medical records were screened through 
November 1st, 2015.
Page 10 of 34
http://www.aogs-online.com































































The Regional Committee for Medical and Health Research Ethics (REC-North ref. number 
2012/1238/REK nord; date of approval: 8 April 2013), and the Patient Ombudsman, Nordland 
Hospital, Bodø, have reviewed and approved the study protocol.
Results
Women with MUI as indication for surgery were significantly older, had higher body mass 
index and parity order, and had more often co-morbidities compared to women having pure 
SUI as indication for surgery (Table 1). Before surgery, women with MUI more often 
practiced electrostimulation alone or in combination with pelvic floor muscle training 
compared to women with SUI (p < 0.001), while women with SUI more frequently performed 
pelvic floor muscle training, only (Table 2). The preoperative evaluations of the stress-test, 
uroflowmetry, cystometry and measurement of residual urine were performed in almost 100% 
of the women (Table 2).
The surgeries were performed as day surgery procedures from 2005 and onwards. Mean 
postoperative hospital stay was 1.0 day (range 0-15). 10 patients (1.7%) had a protracted 
postoperative hospital stay of > 7 days due to infection and UR.
499/596 patients (83.7%) had their first follow-up within 12 months, 454 (76.2%) visited the 
outpatient clinic, and 45 patients (7.6%) responded to a standardized questionnaire either by 
post or phone.  From interview and questionnaire data at the first postoperative follow-up, 
95.7% of SUI women and 82.1% of MUI women were “satisfied” or “very satisfied” (p < 
0.01). UR and/or recurrence were significantly associated with not being satisfied.
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18 patients (3.0%), residing in Nordland County at the time of surgery, moved later to other 
regions of Norway, while 39 patients (6.5%) died during follow-up.  These patients were 
censored at last follow-up visit if no prior outcome.
Efficacy and risk factor analysis
Table 3 summarizes time to last observation for recurrence-free women, events leading to 
premature discontinuation (censoring) and recurrence rates by study group. In total, 54 
(13.8%)  SUI women and 52 (25.2%) MUI women had recurrence of SUI symptoms within 
10 years of surgery (p = 0.001). There was no difference in the number of cases censored by 
study group (Table 3). Mean recurrence-free follow-up time in SUI and MUI women were 
53.8 and 46.0 months (p = 0.02), respectively.
In the assessment of complications as a risk factor for recurrence, perioperative complications 
except UR applied to women with SUI, only. Whereas none of 8 MUI women with other 
perioperative complications had recurrence, 11 out of 25 (44%) SUI women with the above 
mentioned complications had recurrence. Women with other perioperative complications had 
a HR for recurrence of 2.5 (95% CI; 1.3-4.7) relative to women without such complications, 
whereas mixed incontinent women had a HR for recurrence of 2.1 (95% CI; 1.4-3.0) 
compared to stress incontinent women.  Neither age, overweight, parity, previous 
hysterectomy, comorbidities listed in Table 1 nor UR were independent risk factors for 
recurrence and had only minor confounding effects (< 4%) on the primary outcome. In the 
same model the HR for recurrence was 4.0 (95% CI; 2.4-6.7) in the 3rd compared with the 1st 
time period. Cumulative cure rates after one, five and 10 years by indication for surgery and 
in total are shown in Table 4, whereas Figure 2 displays continuous cumulative recurrence 
rates by indication for surgery.
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Two patients (0.3%) had recurrent surgery 17 and 68 months after primary surgery, 
respectively. 
Complications
5.2% of the patients had UR (Table 5), 22 out of these 31 patients recovered within three 
months after surgery (10 recovered spontaneously after a period with self-catheterization, 10 
after traction of the tape, and two after the tape was cut). Four out of the remaining nine 
patients reporting UR more than three months after surgery had the tape cut. All patients with 
UR > 3 months after surgery were after a clinical examination offered cutting of the tape. 
However, as cutting the tape entails a risk of recurrent UI, these five patients preferred, after 
extensive counseling, to continue self-catheterization .
Other perioperative complications remained stable by study groups (Table 5) and over the 
time periods apart from seven bladder perforations observed during the first time period vs. 
one in the third period (p < 0.04). Among patients with other perioperative complications, one 
needed evacuation of an infected hematoma and two patients needed repeat surgery with total 
removal of the tape because of pain or graft-related problems. Three patients had the tape 
removed at primary surgery due to bladder perforation. 
17 (2.9%) women had late tape complications within 10 years after primary surgery (Table 5). 
Two women developed a fistula, one vesico- and one urethro-vaginal. Seven of the 12 
patients with erosions had neither symptoms nor recurrence at the time of diagnosis. The rate 
of surgery due to late complications was 1.3% (n = 8); partial resection of the tape due to 
erosion (n = 6), fistula (n = 1) and pain (n = 1). The second patient with fistula 
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(vesicovaginal) recovered with conservative treatment. Six patients with erosion were also 
treated conservatively with local estrogens without surgery. Mean time from primary surgery 
to surgery for late complication was 52 months (range 5-120 months). 
Discussion
Main findings 
MUI predicted recurrence 10 years after primary TVT surgery. We did not find any 
association between age, overweight, parity, comorbidities, UR and recurrence of SUI.
Efficacy and risk factor analyzes
Among patients not satisfied with the treatment, recurrence and UR within one year impacted 
on dissatisfaction. Already at the first follow-up visit we found a significantly lower 
satisfaction rate in MUI-operated compared to SUI-operated women. As there were 
differences in follow-up time across the study period, with a shorter observation time in the 
3rd time period relative to the previous periods, we performed a Cox regression analysis of 
recurrence through four years of observation in order to avoid attrition bias. The overall HR 
for recurrence in the 3rd compared to the 1st time period dropped from 4.0 to 2.2 (95% CI: 1.2-
4.0) indicating that attrition bias may account for 45% of the difference in HR for recurrence 
between the 3rd and the 1st time period. At the start of the 3rd time period our department 
initiated a systematic 3-year follow-up by a postal questionnaire. A larger proportion of 
women were below 50 years of age (47.8% vs. 35.4%) in the 3rd compared to the 1st time 
period. We ascribe this to increasing awareness of TVT as an improved method for treatment 
of female incontinence. Furthermore, a higher expectation for cure after surgery may have led 
some women in the 3rd period to seek medical advice for UI at a threshold that may have 
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differed to women in the 1st period. These circumstances may have led to a reporting bias 
important for interpretation of the increased HR for recurrence in the 3rd versus the 1st period. 
The overall cumulative subjective cure rate after 10 year follow-up (69%) was somewhat 
lower than results from comparable studies (75-80%). 7-8  When we stratified our results into 
pure SUI and MUI, the cumulative subjective cure rate after 10 year follow-up was 74% for 
the women with pure SUI (95% CI; 66-82%) and 58 % for the MUI women. The long-term 
SUI cure rate was thus lower in our study compared to what has been reported by others (77-
90%), 5-6 while the mixed incontinent women had a higher cumulative subjective cure rate 
compared to other studies (37-55%). 11-12 In line with other reports we found that the effect of 
surgery decreased more with time in mixed incontinent women than SUI women (Figure 2). 19 
As our study analyzed cure rates using survival analyses, we expected the estimates of cure 
rates to be lower, as recurrence is estimated only among patients remaining in the study at the 
different time intervals. This differs significantly from most other studies in which time most 
often is not taken into account when estimating recurrence using the total number of patients 
having surgery as the denominator. 5-6, 9-10  
In studies showing an association between overweight, advanced age and lower cure rates, the 
results may be influenced by including in the study populations women with past UI surgery 
and/or past or concomitant prolapse surgery, which is not the case in our study. 
The rates of repeat surgery due to recurrence vary in the literature from 0-4%. 5-6, 9-10 Studies 
reporting “no” repeat surgery often comprise low-risk populations having included only 
primary surgeries on pure SUI women. 5-6 
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Only a few studies have demonstrated perioperative complications as an independent risk 
factor for recurrence. 9, 15  Our study finds a possible association between recurrence and non-
UR perioperative complications. However, due to low number of cases with such 
complications and inconsistency between SUI and MUI women, this finding has to be 
interpreted with caution. 
Complications
Most studies assessing UR include the need for catheterization resolving spontaneously within 
one week after surgery, leading to large variations in published rates of women with 
postoperative UR. 21-23  In our study, only nine patients (1.5%) reported serious problems with 
bladder emptying more than three months after surgery. Other studies assessing UR after TVT 
report 1.2% rate of “very disturbing UR” more than one year after TVT. 22-24
In 2015, an editorial from the Cochrane library questioned the safety of sub-urethral slings. 25 
In this editorial, the authors referred to a report from the UK Medicines and Healthcare 
Products Regulatory Agency (MHRA), claiming serious and debilitating problems reported 
by women operated for UI with vaginal tape implants.26  Ho ever, in our study, only 2.9% of 
the patients had experienced long-term tape-related problems. Of these less than 50% were in 
need of repeat surgery due to complications, and only two patients needed major surgery, one 
due to fistula, and one with resection of the tape due to pain. This is in accordance with most 
other long-term studies stating an incidence of tape complications varying from < 1% to 
3.5%. 10, 27
Strengths and limitations of the study
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Compared to most studies reporting outcome of incontinence surgery, our study has a large 
sample size, long follow-up time and a high follow-up rate (596/621) as we included 
information from neighboring hospitals in follow-up. In order to avoid any confounding effect 
of earlier pelvic floor surgery on the efficacy, we have included only primary surgeries, and in 
our analysis of recurrence, patients were censored at the date of surgery due to prolapse or 
complications. Over the years surgeries and postoperative follow-up have been performed in 
our department in a standardized manner and by a limited number of surgeons.
The most important weaknesses of this study are the retrospective design, the possibility for 
bias due to changes in quality of reporting across the study periods and the possible loss to 
follow-up by women having repeat surgery at hospitals in other parts of Norway. However, a 
report from Auditor General of Norway stated that Norwegian patients have high loyalty to 
their local hospitals, especially in the rural areas in northern and western Norway.28  This 
report supports that escape of patients out of the catchment area of our hospital is of limited 
magnitude.
Conclusion
Retropubic TVT is a surgical method with high long-term safety and efficacy with low risk of 
long-term serious tape complications. MUI is a risk factor for long-term recurrence.
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Figure 1 Flowchart of study participation
Eligible patients  (n = 895)
Burch procedure due to prolapse (n = 26)
Previous pelvic floor surgery (n = 60)
 Urinary incontinence n = 28
 Prolapse (n = 24)
 Concomitant urinary incontinence and 
prolapse surgery (n = 8)
Concomitant prolapse surgery (n = 5)
Primary incontinence surgeries other than TVT (n = 183)
 Open Burch procedures (n = 127)
 Laparoscopically performed Burch procedures (n = 42)
 Others (n = 14)
Primary TVT surgeries (n = 621)
No follow-up (n = 25)
Primary TVT surgeries (n = 596)
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Age (yrs.)                                                                                     
28-49                                                                                                                      
50-59             








Body mass index (kg/m2)                                                        
Missing                                                                        
          18.29-24.99                                            





















Hysterectomy (yes) 12.8 14.1 = 0.67
Comorbidity                                                        
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Tabell 2. Preoperative conservative treatment and clinical examinations performed 







Electrical stimulation 3.6 14.6
Pelvic floor muscle training 49.0 24.3
Both electrical stimulation and pelvic 
floor muscle training
5.9 16.0
Neither electrical stimulation nor pelvic 
floor muscle training/data missing
41.5 45.1
Clinical assessments performed
Stress test 100.0 99.0
Measure of residual urine 99.2 98.1
Uroflowmetry 94.9 92.7
Cystometry 93.0 97.6
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Outcomes % % %
Time to last observation among recurrence-free women  
Follow-up < 1 year 18.7 15.0 17.4
Follow-up 1-5 years 28.5 28.6 28.5
Follow-up ≥ 5 years 33.8 25.2 30.9
Events leading to censoring
Removal of tape immediate perioperatively (n = 5)  0.8 1.0 0.8
Other surgery due to other periop. compl. (n = 1) 0.3 - 0.2
UR with cutting of tape (n = 5) 0.5 1.5 0.8
Late tape complications with resection of the tape (n = 3)     0.8 - 0.3
Prolapse surgery (n = 18) 2.8 3.4 3.0
Recurrence 13.8 25.2 17.8
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Table 4.  Cumulative cure rates after one, five and 10 years by indication for surgery 
and in total.
TVT surgery risk group 1 year (95% CI) 5 years (95% CI) 10 years (95% CI)
SUI 94% (92-96%) 85% (81-89%) 74% (66-82%)
MUI 88% (84-92%) 67% (59-75%) 58% (48-68%)
Overall cumulative cure rate 92% (90-94%) 79% (75-83%) 69% (63-75%)
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N % N %
Urinary retention (UR) 22 5.6 9 4.4
Other perioperative complications 25 6.4 8 3.9
Bleeding/hematoma 10 2.6 3 1.5
Bladder perf./injury 10 2.6 2 1.0
Others* 5 1.3 3 1.5
Late tape complications within 10 years 13 3.3 4 1.9
Erosion 10 2.6 2 1.0
Pain 1 0.3 2 1.0
Fistula 2 0.5 0 0
*Five patients with superficial surgical site infection and four with other complications.
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Figure 2 Cumulative rates of recurrence of stress incontinence after TVT surgery by 
indication for surgery.
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Figure 1 Flowchart of study participation
Eligible patients  (n = 895)
Burch procedure due to prolapse (n = 26)
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1 Figure 2 Cumulative rates of recurrence of stress incontinence after TVT surgery by 
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